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Abstract. Protein-protein interaction (PPI) and biomolecular pathway data hold 
tremendous potential for drug discovery and development. However, relevant data 
sources are currently distributed across a wide range of disparate, large-scale, pub-
licly-available databases, web sites and repositories and are described using a 
wide range of taxonomies and ontologies. Sophisticated integration, manipulation, 
processing and analysis of these data sets are required in order to reveal previous-
ly undiscovered interactions and pathways that will lead to the discovery of new 
drugs. The Semantic Web has been investigated as a solution to this problem by a 
number of projects that use RDF and OWL to integrate, represent and analyze 
protein interaction data. However, existing applications have suffered from certain 
limitations that hinder their usefulness. In this paper, we describe work being un-
dertaken within the BioMANTA project that aims to identify and overcome the 
limitations associated with the application of Semantic Web technologies to pro-
tein interaction network analysis. In particular we describe the BioMANTA OWL 
ontology that has been designed to enable multiple data sources to be integrated 
within a single RDF triple store through a common PPI model. The primary aim 
of the BioMANTA ontology is to provide a practical means of facilitating the in-
tegration of semantically disparate data sets – it does not aim to provide a precise 
biological, chemical or physical model of how proteins interact.  We also describe 
how this ontology was developed through the refinement, harmonization and ex-
tension of existing ontologies. Finally, we describe the mapping, integration and 
querying of a range of protein-protein interaction data sets, based on the ontology. 
1. Introduction 
BioMANTA is a collaborative systems biology project focused on in silico drug discov-
ery through integrated data set analysis of molecular interactions and biochemical path-
ways. This requires real-time analysis and feedback, across large disparate data sets in 
order to identify lead candidates or new interaction networks. It draws on a large num-
ber of publicly available databases of varying size, specialization, coverage and reliabil-
ity. The data sets of relevance are in different formats, are generated through widely 
varying methodologies and are described using very different vocabularies and termi-
nologies. 
The Semantic Web technologies, OWL and RDF, were chosen as the platform for 
representing, modeling and analyzing protein-protein interaction (PPI) and molecular 
pathway data as they provide a formal and extensible semantics, ideal for data integra-
tion [Belleau et al. 2007]. A number of projects including the Gene Ontology [Ashburn-
er et al. 2000] and the OBO ontology [Smith et al. 2007] have previously used RDF and 
OWL to mark up biological knowledge and enable additional reasoning. In addition, a 
number of ontologies covering different aspects of systems biology and protein interac-
tion networks have also been developed: biological processes and molecular function 
(GO), phylogenetic classifications (NCBI taxonomy), sequence annotation (Sequence 
Ontology), molecular interactions (PSI-MI), cell types (Cell Type Ontology) and path-
ways (BioPax). However, there does not exist a unified representation of all of the con-
cepts that a biologist might consider relevant to the study of protein-protein interactions 
within a single OWL ontology.  
Within the BioMANTA project, a high-level, extensible ontology has been created to 
integrate concepts from relevant existing ontologies. This ontology serves as a basis on 
which knowledge relevant to PPI can be harmonized, providing coverage over a wide 
conceptual space. It is also used to formalize and validate the properties used in our 
integration process - a challenging task which demands scalability, efficiency and accu-
racy over the very large scale data sets involved. 
2. The BioMANTA Ontology 
Fig. 1. Overview of BioMANTA Ontology 
 
The BioMANTA ontology [M. Davis et al. 2008]1 is an OWL DL ontology focusing on 
integrated concepts from: PSI-MI2, BioPAX level 2 [BioPAX Workgroup 2004], Cell 
Type [Bard et al. 2005], Gene Ontology [Bard 2005] and NCBI Taxonomy3.  The ontol-
ogy combines the use of top-down and bottom-up development - incorporating terms as 
appropriate and required in order to leverage existing data sets.  We have reused voca-
bularies where appropriate. For example, we incorporated the Cell Type ontology (a 
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structured controlled vocabulary4 taken from OBO Foundry) after it was converted to 
OWL format5.  
Our approach to knowledge representation combines the three different levels of atti-
tude to data modeling [Ruttenberg et al. 2006].  Our ontology allows us to express: 
“there exists a protein” (the domain level) and “database A says it has these properties 
and database B says it has these properties” (the record level).  We also align the expe-
rimental provenance information (statement level) to improve query quality – allowing 
us to filter out various experimental types.  This work is based on object identification 
or record linkage [Batini and Scannapieca 2006] which seeks to integrate various data 
sets across databases and the Semantic Web [Guha 2004].   
In the ontology, the hierarchical but expressive properties of PSI-MI are combined 
with the extensibility and richer relationships available in BioPAX (expressed in OWL).  
Among others, the ontology consists of the following key concepts: 
• Different types of Observation including: Experimental, Predicted, and Inferred; and 
• Provenance information including: data source, the type of experiment, the cell type, 
inferencing method, sub-cellular location and observation reference (a BioPAX pub-
lication cross reference). 
While BioPAX is expressed in OWL there are numerous issues with its modeling ap-
proach  [Ruttenberg et al. 2006] [Ruttenberg et al. 2005] [Motik et al. 2007].  One of the 
most detrimental aspects, with respect to our requirements, was the lack of context or 
meaning when the openControlledVocabulary class is used to link to external 
terms.  This was overcome by using URIs instead of string literals.  We also developed 
a process which involved converting (the Cell Type ontology) from OBO to OWL and 
defining classes and instances to represent these richer relationships. 
3. The Integration of Biological Data Sets 
Within the BioMANTA project, various PPI-related data sets are integrated to form a 
uniform RDF representation that enables answering of complex queries. In this section, 
we present details of the integration process. 
In systems biology, a number of protein databases such as UniProt [Wu et al. 2006], 
DIP [Salwinski et al. 2004], IntAct [Kerrien et al. 2007] and MPact [Guldener et al. 
2006] have been developed. They contain partially overlapping information about a 
wide variety of proteins/genes. However, most of these data sets employ their own nam-
ing conventions. For example, the protein identified as “27628” in DIP is the same pro-
tein as the one identified as “115 dax human” in IntAct.  It is important to be able to 
refer to the real protein by either identifier and to be able to query and retrieve its prop-
erties from both data sets.  Within the various data sets there is also duplication, incon-
sistency and noise. For example, we have noticed that in one particular data set, mul-
tiple different proteins have been mapped to the same ID. Hence, relying on the match-
ing of names from different data sets is not entirely reliable. For this reason, we decided 
to integrate the databases using a combination of the UniProt ID and genomic sequence 
to uniquely identify a protein.  These two values are then associated with a protein in-
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stance, without a name from any particular database but instead, using a blank node. 
The integration process can be conceptually viewed as the following set of steps. 
1. PSI-MI to RDF translation - XML data sets in PSI-MI [Hermjakob et al. 2004] 
format are translated to RDF. In this step, all the information associated with proteins 
and interactions in PSI-MI is modeled using RDF constructs, concepts and properties 
defined in the BioMANTA ontology. For example, the organism, the local identifiers 
and the genomic sequence information are captured as RDF triples.  
2. UniProt ID augmentation - UniProt is a comprehensive protein database. We de-
cided to use UniProt IDs in the integration process to merge proteins from different 
data sets. However, not all data sets contain UniProt IDs. In this step, with the help of 
external mapping files between local IDs and UniProt IDs, a UniProt ID is added to 
each protein instance. 
3. Sequence augmentation – Proteins that have genomic sequences can be disambi-
guated by evaluating the sequence, using such tools as Blast, and equivalent se-
quences are used to identify proteins across data sources. In this step, all the missing 
sequences of proteins are added to the RDF instances from external mapping files for 
individual data sets.  
4. Protein integration - Matching UniProt IDs and sequences, the final step merges 
proteins from different data sets into a single, uniform representation. Proteins with 
different UniProt IDs are considered to be different ones; those with same UniProt 
IDs but different sequences generate warnings; proteins with matching IDs and se-
quences will be merged into a single protein, together with their annotations.   
Figure 2 depicts a merged protein with UniProt ID “Q12522”, it shows the result of 
merging instance data from the MIPS and UniProt databases.  We have kept the various 
synonyms from both databases: “CDC95” and “elF6”.  This allows queries that only use 
one of the databases to find data related to the protein, in another database. Note that 
ovals represent RDF blank nodes and squares represent RDF URI references or literals. 
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Fig. 2. A protein instance, merged from UniProt and MIPS, using UniProt ID and sequence. 
As the BioMANTA ontology uses concepts from NCBI the integrated protein data 
can be used for inferring certain relationships such as “all mammalian interactions” as 
well as determining the quality of the observation based on experiment type.  This rea-
soning can be employed to filter the data and improve its quality during the integration 
process by only incorporating observations that have occurred within mammals. 
Although the aim of the BioMANTA project is to enable drug discovery and to iden-
tify therapeutic targets, data sets about yeast (Saccharomyces cerevisiae, NCBI Tax-
onomy ID 4932) have also been used to evaluate the feasibility of the approach - be-
cause of their relative simplicity. 
4. Conclusions 
The BioMANTA project aims to apply Semantic Web technologies to the modeling, 
integration, analysis and querying of protein-protein interaction data. An OWL ontology 
has been developed to overcome limitations of existing ontologies, and to better enable 
the representation, integration, querying of and reasoning across complex protein-
protein interactions and molecular pathways.  Based on the BioMANTA ontology, an 
integration process has been designed and implemented to translate, augment and inte-
grate different complementary data sets on protein-protein interactions and biological 
pathways, in order to assist biologists with the discovery and design of new drugs. 
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